Aging‐associated up‐regulation of neuronal 5‐lipoxygenase expression: putative role in neuronal vulnerability-Reference-Cited by-同舟云学术

Aging‐associated up‐regulation of neuronal 5‐lipoxygenase expression: putative role in neuronal vulnerability

Published:1998-04 Issue:6 Volume:12 Page:439-449
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Uz Tolga¹,Pesold Christine¹,Longone Patrizia¹,Manev Hari¹

Affiliation:

1. The Psychiatric InstituteUniversity of Illinois at Chicago Chicago Illinois 60612 USA

Funder

National Institutes of Health

Fogarty International Center

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fasebj.12.6.439

Reference53 articles.

1. Leukotrienes and other products of the 5‐lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.;Lewis R. A.;New Engl. J. Med.,1990

2. Lipoxygenase products of polyunsaturated fatty acid metabolism in the central nervous system: Biosynthesis and putative functions

3. Eicosanoids in synaptic transmission.;Piomelli D.;Crit. Rev. Neurobiol.,1994

4. Synthesis of Compounds with Properties of Leukotrienes C 4 and D 4 in Gerbil Brains After Ischemia and Reperfusion

5. Protection from hypoxic and N-methyl-D-aspartate injury with azelastine, a leukotriene inhibitor

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Driving factors of neuronal ferroptosis;Trends in Cell Biology;2024-07

2. Leukotriene signaling as molecular correlate for cognitive heterogeneity in aging: an exploratory study;Frontiers in Aging Neuroscience;2023-08-02

3. Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases;Frontiers in Oncology;2022-03-10

4. Citric Acid Administration Protects Against Insulin-Induced Hypoglycemic Brain and Liver Injury;WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE;2022-02-01

5. Targeted delivery of montelukast for treatment of Alzheimer’s disease;CNS & Neurological Disorders - Drug Targets;2021-09-02